Evidence-Based Medicine Guidelines
Cyclosporin for psoriasis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cyclosporin for Psoriasis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453191/all/Cyclosporin_for_psoriasis.
Cyclosporin for psoriasis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/453191/all/Cyclosporin_for_psoriasis. Accessed June 5, 2023.
Cyclosporin for psoriasis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/453191/all/Cyclosporin_for_psoriasis
Cyclosporin for Psoriasis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453191/all/Cyclosporin_for_psoriasis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cyclosporin for psoriasis
ID - 453191
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453191/all/Cyclosporin_for_psoriasis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
